Home LiteratureArticle Details

PMID: 12560281 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Pathogenesis of sepsis: new concepts and implications for future treatment.

BMJ (Clinical research ed.) ·Vol. 326 ·No. 7383 ·2003-02-01 ·Pages 262-6

Bochud PY, Calandra T

Abstract

暂无摘要

MeSH Terms

Anti-Bacterial Agents/therapeutic use Drosophila Proteins Genetic Predisposition to Disease Gram-Negative Bacterial Infections/microbiology,therapy Gram-Positive Bacterial Infections/microbiology,therapy HMGA1a Protein/therapeutic use Humans Macrophage Migration-Inhibitory Factors/therapeutic use Membrane Glycoproteins/analysis Receptors, Cell Surface/analysis Sepsis/microbiology,therapy Toll-Like Receptors

Chemicals

Anti-Bacterial Agents Drosophila Proteins Macrophage Migration-Inhibitory Factors Membrane Glycoproteins Receptors, Cell Surface Toll-Like Receptors HMGA1a Protein

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Bochud Pierre-Yves

Institute for Systems Biology, 1441 North 34th Street, Seattle, WA 98103-8904, USA.

Calandra Thierry

References (30)

30 references, click to expand

Early goal-directed therapy in the treatment of severe sepsis and septic shock.
N Engl J Med. 2001 Nov 8;345(19):1368-77 PMID: 11794169
Intensive insulin therapy in critically ill patients.
N Engl J Med. 2001 Nov 8;345(19):1359-67 PMID: 11794168
MIF regulates innate immune responses through modulation of Toll-like receptor 4.
Nature. 2001 Dec 20-27;414(6866):920-4 PMID: 11780066
Drosophila innate immunity: an evolutionary perspective.
Nat Immunol. 2002 Feb;3(2):121-6 PMID: 11812988
Innate immune recognition.
Annu Rev Immunol. 2002;20:197-216 PMID: 11861602
Toll-like receptors as adjuvant receptors.
Biochim Biophys Acta. 2002 Feb 13;1589(1):1-13 PMID: 11909637
Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
Clin Infect Dis. 2002 Apr 15;34(8):1084-93 PMID: 11914997
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
Immunity. 1999 Oct;11(4):443-51 PMID: 10549626
Pathogenesis of septic shock: implications for prevention and treatment.
J Chemother. 2001 Nov;13 Spec No 1(1):173-80 PMID: 11936363
Essential role of MD-2 in LPS responsiveness and TLR4 distribution.
Nat Immunol. 2002 Jul;3(7):667-72 PMID: 12055629
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
JAMA. 2002 Aug 21;288(7):862-71 PMID: 12186604
Cytokines in septic shock.
Curr Clin Top Infect Dis. 2002;22:1-23 PMID: 12520644
Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
J Exp Med. 1989 Jun 1;169(6):2021-7 PMID: 2659724
From the Centers for Disease Control. Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987.
JAMA. 1990 Feb 16;263(7):937-8 PMID: 2299753
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.
Nature. 1993 Oct 21;365(6448):756-9 PMID: 8413654
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science. 1998 Dec 11;282(5396):2085-8 PMID: 9851930
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.
J Exp Med. 1999 Jan 18;189(2):341-6 PMID: 9892616
Recognition of gram-negative bacteria and endotoxin by the innate immune system.
Curr Opin Immunol. 1999 Feb;11(1):19-22 PMID: 10047547
Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock.
J Infect Dis. 1999 Jul;180(1):116-21 PMID: 10353869
HMG-1 as a late mediator of endotoxin lethality in mice.
Science. 1999 Jul 9;285(5425):248-51 PMID: 10398600
Protection from septic shock by neutralization of macrophage migration inhibitory factor.
Nat Med. 2000 Feb;6(2):164-70 PMID: 10655104
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13766-71 PMID: 11095740
A Toll-like receptor recognizes bacterial DNA.
Nature. 2000 Dec 7;408(6813):740-5 PMID: 11130078
Efficacy and safety of recombinant human activated protein C for severe sepsis.
N Engl J Med. 2001 Mar 8;344(10):699-709 PMID: 11236773
Antibiotics in sepsis.
Intensive Care Med. 2001;27 Suppl 1:S33-48 PMID: 11307369
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.
Nature. 2001 Apr 26;410(6832):1099-103 PMID: 11323673
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.
Crit Care Med. 2001 Jul;29(7):1303-10 PMID: 11445675
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Crit Care Med. 2001 Jul;29(7 Suppl):S13-5 PMID: 11445727
Bacterial lipopolysaccharides and innate immunity.
J Endotoxin Res. 2001;7(3):167-202 PMID: 11581570
HMGB1 as a late mediator of lethal systemic inflammation.
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1768-73 PMID: 11734424

Article Info

Journal

BMJ (Clinical research ed.)

Abbr.

BMJ

ISSN

1756-1833

DOI

10.1136/bmj.326.7383.262

Published

2003-02-01

Pages

262-6

Language

English

Region

England

NLM ID

8900488

PMCID

PMC1125122

Subset

External Links

PubMed source DOI: 10.1136/bmj.326.7383.262 PMC Full Text View journal details

Analysis Services

Pathogenesis of sepsis: new concepts and implications for future treatment.

Contact

WeChat Official Account